|
Identification of susceptibility to chemotherapy induced peripheral neuropathy using patient stem cell derived sensory neurons
|
1R03CA220219-01
|
$88,500
|
$88,500
|
WOOLF, CLIFFORD
|
BOSTON CHILDREN'S HOSPITAL
|
|
Elucidating the Regulation and Function of the NF1 tumor suppressor
|
5R01CA111754-12
|
$316,635
|
$158,318
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Developmental and HyperActive Ras Tumor SPORE
|
5U54CA196519-03
|
$2,271,783
|
$1,908,298
|
CLAPP, DAVID
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
(PQ 6) Exploiting Frequent Alterations in the PRC2 Complex to Distinguish Benign Neurofibromas from Malignant Peripheral Nerve Sheath Tumors
|
5R21CA208723-02
|
$177,852
|
$177,852
|
BETTEGOWDA, CHETAN
|
JOHNS HOPKINS UNIVERSITY
|
|
Phase II trial of mTORC1/mTORC2 inhibitor AZD2014 for sporadic meningioma
|
5R01CA201130-02
|
$401,017
|
$401,017
|
RAMESH, VIJAYA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-43S1
|
$60,000
|
$600
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-43S2
|
$75,000
|
$750
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-43S3
|
$749,911
|
$7,499
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
5P30CA015083-43
|
$5,815,389
|
$58,154
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Molecular Basis of Familial Paraganglioma
|
5R01CA166025-05
|
$296,933
|
$296,933
|
MAHER, LOUIS
|
MAYO CLINIC ROCHESTER
|
|
Phospholipid and Sphingolipid Signaling in Drosophila
|
ZIA BC 010331
|
$147,835
|
$147,835
|
Acharya, Jairaj
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$755,842
|
$37,792
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Natural History and Specimen Banking for Patients with CNS Tumors
|
ZIA BC 011768
|
$548,393
|
$548,393
|
Armstrong, Terri
|
CCR (NCI)
|
|
Studies of amplification in rhabdomyosarcoma
|
ZIA BC 011378
|
$218,891
|
$21,889
|
Barr, Frederic
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,094,457
|
$109,446
|
Barr, Frederic
|
CCR (NCI)
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIA BC 011470
|
$312,747
|
$125,099
|
Beutler, John
|
CCR (NCI)
|
|
Oncogenic Met Signaling in Urologic Malignancies
|
ZIA BC 011124
|
$356,352
|
$35,635
|
Bottaro, Donald
|
CCR (NCI)
|
|
BKV and JCV vaccine development
|
ZIA BC 011460
|
$362,249
|
$108,675
|
Buck, Christopher
|
CCR (NCI)
|
|
Stable Water Isotope Labeling for Imaging of Rapidly Proliferating Cells
|
ZIA BC 011777
|
$24,641
|
$5,175
|
Buxbaum, Nataliya
|
CCR (NCI)
|
|
Molecular Profiling of Patients Undergoing Radiotherapy
|
ZIA SC 010372
|
$427,230
|
$299,061
|
Camphausen, Kevin
|
CCR (NCI)
|
|
The Synergy Between Radiotherapy and Molecularly Targeted Agents
|
ZIA SC 010373
|
$640,845
|
$512,676
|
Camphausen, Kevin
|
CCR (NCI)
|
|
Radiation Oncology Branch - Radiation Clinic
|
ZID BC 010990
|
$4,983,045
|
$797,287
|
Camphausen, Kevin
|
CCR (NCI)
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research
|
ZIG BC 010856
|
$14,497,944
|
$724,898
|
Custer, Mary
|
CCR (NCI)
|
|
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
|
ZIA BC 010006
|
$427,953
|
$64,193
|
Daar, Ira
|
CCR (NCI)
|
|
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
|
ZIA BC 010958
|
$427,953
|
$149,783
|
Daar, Ira
|
CCR (NCI)
|
|
Effects of Cytosine Modifications on Transcription Factor Binding
|
ZIC BC 011724
|
$136,721
|
$136,721
|
Durell, Stewart
|
CCR (NCI)
|
|
Clinical Pharmacogenetics
|
ZIA BC 010627
|
$738,087
|
$36,904
|
Figg, William
|
CCR (NCI)
|
|
Exploring the Therapeutic Potential of Stem Cell Biology in Gliomas
|
ZIA BC 011640
|
$194,156
|
$194,156
|
Gilbert, Mark
|
CCR (NCI)
|
|
Rare Central Nervous System Cancers Initiative
|
ZIA BC 011643
|
$271,818
|
$271,818
|
Gilbert, Mark
|
CCR (NCI)
|
|
Identifying New Glioma-Associated Tumor Suppressors & Oncogenes
|
ZIA BC 011647
|
$271,818
|
$271,818
|
Gilbert, Mark
|
CCR (NCI)
|
|
Brain Tumor Immunotherapy
|
ZIA BC 011714
|
$271,818
|
$271,818
|
Gilbert, Mark
|
CCR (NCI)
|
|
Bioinformatics: Characterizing Brain Tumor Date
|
ZIA BC 011784
|
$77,662
|
$77,662
|
Gilbert, Mark
|
CCR (NCI)
|
|
Pre-clinical Translational Research Facility
|
ZIC BC 011641
|
$1,242,597
|
$1,242,597
|
Gilbert, Mark
|
CCR (NCI)
|
|
Brain Tumor Clinical and Clinical Research Program
|
ZID BC 011642
|
$1,553,246
|
$1,553,246
|
Gilbert, Mark
|
CCR (NCI)
|
|
Pediatric Oncology Branch Behavioral Science Core
|
ZID BC 011517
|
$895,830
|
$895,830
|
Glod, John
|
CCR (NCI)
|
|
Pediatric Oncology Branch Clinical Care and Education
|
ZIE BC 011516
|
$3,583,320
|
$1,433,328
|
Glod, John
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$587,732
|
$105,792
|
Gottesman, Michael
|
CCR (NCI)
|
|
Mechanism, Regulation and Application of miRNA pathway in cancer
|
ZIA BC 011566
|
$686,859
|
$137,372
|
Gu, Shuo
|
CCR (NCI)
|
|
Development of new antibody-based cancer therapies
|
ZIA BC 010891
|
$942,291
|
$47,115
|
Ho, Mitchell
|
CCR (NCI)
|
|
Brain Interstitium Temozolomide Concentration Pre and Post Regadenoson
|
ZIA BC 011685
|
$70,912
|
$70,912
|
Jackson, Sadhana
|
CCR (NCI)
|
|
Modulating BBB Permeability in Malignant Glioma
|
ZIA BC 011686
|
$283,650
|
$283,650
|
Jackson, Sadhana
|
CCR (NCI)
|
|
Characterization of Biological Nanoparticle Subsets
|
ZIA BC 011502
|
$248,748
|
$12,437
|
Jones, Jennifer
|
CCR (NCI)
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$474,811
|
$94,962
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
|
ZIA BC 011334
|
$474,811
|
$94,962
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Mechanisms of transcription fidelity in prokaryotes and eukaryotes
|
ZIA BC 010795
|
$650,373
|
$325,186
|
Kashlev, Mikhail
|
CCR (NCI)
|
|
Developing Novel Therapies for Neuroblastoma and Rhabdomyosarcoma
|
ZIA BC 010806
|
$170,385
|
$85,192
|
Khan, Javed
|
CCR (NCI)
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$511,155
|
$230,020
|
Khan, Javed
|
CCR (NCI)
|
|
Bioinformatics: Systems Biology of Pediatric Cancers
|
ZIA BC 011002
|
$340,770
|
$340,770
|
Khan, Javed
|
CCR (NCI)
|
|
Identification of Genes for Predicting Prognosis in Pediatric Cancers
|
ZIA SC 010366
|
$170,385
|
$85,192
|
Khan, Javed
|
CCR (NCI)
|
|
Postmortem Pathology
|
ZIC BC 010685
|
$699,211
|
$69,921
|
Kleiner, David
|
CCR (NCI)
|
Total relevant funding to Nervous System for this search: $33,640,923
|